haloperidol has been researched along with Prostatic Neoplasms in 13 studies
Haloperidol: A phenyl-piperidinyl-butyrophenone that is used primarily to treat SCHIZOPHRENIA and other PSYCHOSES. It is also used in schizoaffective disorder, DELUSIONAL DISORDERS, ballism, and TOURETTE SYNDROME (a drug of choice) and occasionally as adjunctive therapy in INTELLECTUAL DISABILITY and the chorea of HUNTINGTON DISEASE. It is a potent antiemetic and is used in the treatment of intractable HICCUPS. (From AMA Drug Evaluations Annual, 1994, p279)
haloperidol : A compound composed of a central piperidine structure with hydroxy and p-chlorophenyl substituents at position 4 and an N-linked p-fluorobutyrophenone moiety.
Prostatic Neoplasms: Tumors or cancer of the PROSTATE.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Tamoxifen (TAM) has previously been shown to inhibit growth of the Dunning R3327 rat prostate adenocarcinoma and to elevate serum prolactin levels." | 7.67 | Role of prolactin in modulating the effects of tamoxifen on growth of the Dunning R3327 rat prostate adenocarcinoma. ( Ip, MM; Sylvester, PW, 1987) |
| "Tamoxifen (TAM) has previously been shown to inhibit growth of the Dunning R3327 rat prostate adenocarcinoma and to elevate serum prolactin levels." | 3.67 | Role of prolactin in modulating the effects of tamoxifen on growth of the Dunning R3327 rat prostate adenocarcinoma. ( Ip, MM; Sylvester, PW, 1987) |
| "Prostate cancer is the most frequently diagnosed malignancy and the leading cause of cancer related death in men." | 1.46 | Novel small molecule guanidine Sigma1 inhibitors for advanced prostate cancer. ( Chen, N; Kim, FJ; Lou, R; Oyer, HM; Salvino, JM; Srikanth, YVV, 2017) |
| "Pretreatment of haloperidol significantly reduced the radiotracer accumulation of [(99m)Tc]23 or [(99m)Tc]24 in the brain." | 1.40 | Novel cyclopentadienyl tricarbonyl (99m)tc complexes containing 1-piperonylpiperazine moiety: potential imaging probes for sigma-1 receptors. ( Brust, P; Cui, M; Deuther-Conrad, W; Jia, B; Jia, H; Li, D; Liu, B; Lu, J; Steinbach, J; Wang, X; Xie, Y, 2014) |
| "Complex mechanisms of prostate cancer progression prompt to novel therapeutic strategies concerning a combination of drugs or of single molecules able to interact with more crucial targets." | 1.37 | Antiproliferative activity of phenylbutyrate ester of haloperidol metabolite II [(±)-MRJF4] in prostate cancer cells. ( Bernardini, R; Fiorito, J; Marrazzo, A; Pasquinucci, L; Prezzavento, O; Ronsisvalle, G; Ronsisvalle, S; Scoto, GM; Zappalà, L, 2011) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (7.69) | 18.7374 |
| 1990's | 3 (23.08) | 18.2507 |
| 2000's | 2 (15.38) | 29.6817 |
| 2010's | 6 (46.15) | 24.3611 |
| 2020's | 1 (7.69) | 2.80 |
| Authors | Studies |
|---|---|
| Marrazzo, A | 2 |
| Fiorito, J | 2 |
| Zappalà, L | 1 |
| Prezzavento, O | 1 |
| Ronsisvalle, S | 1 |
| Pasquinucci, L | 1 |
| Scoto, GM | 1 |
| Bernardini, R | 1 |
| Ronsisvalle, G | 1 |
| Salvino, JM | 1 |
| Srikanth, YVV | 1 |
| Lou, R | 1 |
| Oyer, HM | 1 |
| Chen, N | 1 |
| Kim, FJ | 1 |
| Kopp, N | 1 |
| Holtschulte, C | 1 |
| Börgel, F | 1 |
| Lehmkuhl, K | 1 |
| Friedland, K | 1 |
| Civenni, G | 1 |
| Laurini, E | 1 |
| Catapano, CV | 1 |
| Pricl, S | 1 |
| Humpf, HU | 1 |
| Schepmann, D | 1 |
| Wünsch, B | 1 |
| Wang, X | 1 |
| Li, D | 1 |
| Deuther-Conrad, W | 1 |
| Lu, J | 1 |
| Xie, Y | 1 |
| Jia, B | 1 |
| Cui, M | 1 |
| Steinbach, J | 1 |
| Brust, P | 1 |
| Liu, B | 1 |
| Jia, H | 1 |
| Di Giacomo, V | 1 |
| Di Valerio, V | 1 |
| Rapino, M | 1 |
| Bosco, D | 1 |
| Cacciatore, I | 1 |
| Ciulla, M | 1 |
| Di Stefano, A | 1 |
| Cataldi, A | 1 |
| Evans, JC | 1 |
| Malhotra, M | 1 |
| Fitzgerald, KA | 1 |
| Guo, J | 1 |
| Cronin, MF | 1 |
| Curtin, CM | 1 |
| O'Brien, FJ | 1 |
| Darcy, R | 1 |
| O'Driscoll, CM | 1 |
| Rhodius-Meester, HF | 1 |
| Kuper, IM | 1 |
| Otten, HM | 1 |
| Hamburger, HL | 1 |
| Spruce, BA | 1 |
| Campbell, LA | 1 |
| McTavish, N | 1 |
| Cooper, MA | 1 |
| Appleyard, MV | 1 |
| O'Neill, M | 1 |
| Howie, J | 1 |
| Samson, J | 1 |
| Watt, S | 1 |
| Murray, K | 1 |
| McLean, D | 1 |
| Leslie, NR | 1 |
| Safrany, ST | 1 |
| Ferguson, MJ | 1 |
| Peters, JA | 1 |
| Prescott, AR | 1 |
| Box, G | 1 |
| Hayes, A | 1 |
| Nutley, B | 1 |
| Raynaud, F | 1 |
| Downes, CP | 1 |
| Lambert, JJ | 1 |
| Thompson, AM | 1 |
| Eccles, S | 1 |
| Vilner, BJ | 1 |
| John, CS | 2 |
| Bowen, WD | 2 |
| Gulden, ME | 1 |
| Li, J | 1 |
| McAfee, JG | 1 |
| Thakur, ML | 1 |
| Benítez del Rosario, MA | 1 |
| Montón, F | 1 |
| Salinas, A | 1 |
| Martín, JJ | 1 |
| Feria, M | 1 |
| Sylvester, PW | 1 |
| Ip, MM | 1 |
| Nishimaki, T | 1 |
| Furudate, S | 1 |
13 other studies available for haloperidol and Prostatic Neoplasms
| Article | Year |
|---|---|
Antiproliferative activity of phenylbutyrate ester of haloperidol metabolite II [(±)-MRJF4] in prostate cancer cells.
Topics: Animals; Cell Line, Tumor; Cell Proliferation; Guinea Pigs; Haloperidol; Histone Deacetylase Inhibit | 2011 |
Novel small molecule guanidine Sigma1 inhibitors for advanced prostate cancer.
Topics: Animals; ERG1 Potassium Channel; Guanidines; Half-Life; Humans; Male; Mice; Microsomes, Liver; Neopl | 2017 |
Novel σ
Topics: Amination; Animals; Antineoplastic Agents; Cell Line, Tumor; Cell Proliferation; Cyclohexanes; Human | 2021 |
Novel cyclopentadienyl tricarbonyl (99m)tc complexes containing 1-piperonylpiperazine moiety: potential imaging probes for sigma-1 receptors.
Topics: Animals; Brain; Brain Neoplasms; Cell Line, Tumor; Glioma; Haloperidol; Ligands; Male; Mice, Inbred | 2014 |
MRJF4, a novel histone deacetylase inhibitor, induces p21 mediated autophagy in PC3 prostate cancer cells.
Topics: Autophagy; Cell Line, Tumor; Cell Movement; Cyclin-Dependent Kinase Inhibitor p21; Extracellular Sig | 2015 |
Formulation and Evaluation of Anisamide-Targeted Amphiphilic Cyclodextrin Nanoparticles To Promote Therapeutic Gene Silencing in a 3D Prostate Cancer Bone Metastases Model.
Topics: Bone Neoplasms; Cations; Cell Line, Tumor; Chemistry, Pharmaceutical; Cyclodextrins; Gene Silencing; | 2017 |
An unusual presentation of a varicella zoster virus encephalitis in a patient treated for metastatic prostate cancer.
Topics: Acyclovir; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Antipsychotic Agents; | 2010 |
Small molecule antagonists of the sigma-1 receptor cause selective release of the death program in tumor and self-reliant cells and inhibit tumor growth in vitro and in vivo.
Topics: Animals; Antineoplastic Agents; Apoptosis; Breast Neoplasms; Calcium Signaling; Carbazoles; Caspases | 2004 |
Sigma-1 and sigma-2 receptors are expressed in a wide variety of human and rodent tumor cell lines.
Topics: Adenocarcinoma; Animals; Binding, Competitive; Breast Neoplasms; Carcinoma, Ductal, Breast; Glioblas | 1995 |
Synthesis, in vitro binding, and tissue distribution of radioiodinated 2-[125I]N-(N-benzylpiperidin-4-yl)-2-iodo benzamide, 2-[125I]BP: a potential sigma receptor marker for human prostate tumors.
Topics: Animals; Benzamides; Binding, Competitive; Haloperidol; Humans; Indicators and Reagents; Iodine Radi | 1998 |
Charles Bonnet syndrome and opioids.
Topics: Aged; Analgesics, Opioid; Antipsychotic Agents; Blindness; Diagnosis, Differential; Fatal Outcome; H | 2001 |
Role of prolactin in modulating the effects of tamoxifen on growth of the Dunning R3327 rat prostate adenocarcinoma.
Topics: Adenocarcinoma; Animals; Bromocriptine; Cell Line; Drug Therapy, Combination; Haloperidol; Male; Neo | 1987 |
The role of a new liquid-solid scintillator, a mixture of DPO, POPOP and Epon 812, for enhancement of autoradiograms with tritium agents.
Topics: Animals; Antineoplastic Agents; Autoradiography; Epoxy Resins; Humans; Indicators and Reagents; Male | 1998 |